218 related articles for article (PubMed ID: 15687338)
1. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.
Sites CK; L'Hommedieu GD; Toth MJ; Brochu M; Cooper BC; Fairhurst PA
J Clin Endocrinol Metab; 2005 May; 90(5):2701-7. PubMed ID: 15687338
[TBL] [Abstract][Full Text] [Related]
2. Predictors of worsening insulin sensitivity in postmenopausal women.
Goodrow GJ; L'Hommedieu GD; Gannon B; Sites CK
Am J Obstet Gynecol; 2006 Feb; 194(2):355-61. PubMed ID: 16458629
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity.
Cooper BC; Burger NZ; Toth MJ; Cushman M; Sites CK
Am J Obstet Gynecol; 2007 Feb; 196(2):123.e1-7. PubMed ID: 17306648
[TBL] [Abstract][Full Text] [Related]
4. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
Gower BA; Nagy TR; Goran MI; Smith A; Kent E
J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
[TBL] [Abstract][Full Text] [Related]
5. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
Toth MJ; Sites CK; Matthews DE
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
[TBL] [Abstract][Full Text] [Related]
7. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
[TBL] [Abstract][Full Text] [Related]
8. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study.
Walker RJ; Lewis-Barned NJ; Sutherland WH; Goulding A; Edwards EA; de Jong SA; Gold E; Walker HL
Menopause; 2001; 8(1):27-32. PubMed ID: 11201511
[TBL] [Abstract][Full Text] [Related]
9. Previous exposure to hormone replacement therapy and confounders in metabolic studies.
Sites CK; L'Hommedieu GD; Brochu M; Poehlman ET
Menopause; 2001; 8(4):281-5. PubMed ID: 11449086
[TBL] [Abstract][Full Text] [Related]
10. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
13. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
Munoz J; Derstine A; Gower BA
Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
[TBL] [Abstract][Full Text] [Related]
14. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
15. Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Shadoan MK; Anthony MS; Rankin SE; Clarkson TB; Wagner JD
Metabolism; 2003 Sep; 52(9):1085-91. PubMed ID: 14506611
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
Ziaei S; Moaya M; Faghihzadeh S
Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
Sites CK; Brochu M; Tchernof A; Poehlman ET
Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
[TBL] [Abstract][Full Text] [Related]
18. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
Sørensen MB; Rosenfalck AM; Højgaard L; Ottesen B
Obes Res; 2001 Oct; 9(10):622-6. PubMed ID: 11595778
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
Ryan AS; Nicklas BJ; Berman DM
Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
